• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO MEDICAL CORPORATION 6F ANGIO-SEAL EVOLUTION VASCULAR CLOSURE DEVICE, US; DEVICE, HEMOSTASIS, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO MEDICAL CORPORATION 6F ANGIO-SEAL EVOLUTION VASCULAR CLOSURE DEVICE, US; DEVICE, HEMOSTASIS, VASCULAR Back to Search Results
Catalog Number C610134
Medical Device Problem Code Device Operates Differently Than Expected (2913)
Health Effect - Clinical Codes Blood Loss (2597); No Known Impact Or Consequence To Patient (2692)
Date of Event 05/31/2017
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The actual device has not been returned to the manufacturing facility for evaluation.The investigation is currently ongoing.A follow up report will be submitted once the investigation is complete.A review of the device history record of the product code/lot# combination was conducted with no relevant findings.A search of the complaint file did not find any other report with the involved product code/lot# combination.All available information has been placed on file in quality assurance at the manufacturing facility for appropriate tracking, trending and follow-up.
 
Event or Problem Description
The user facility reported pullout with the involved angio-seal evolution device.The following information was provided by the user facility: the customer stated that during deployment, the device (including the anchor) pulled directly out of the body; hemostasis was achieved by manual compression; the blood loss was estimated to be approximately 10 cc's; the patient was reported to be stable; and there was no other equipment or devices being used with the reported product.
 
Additional Manufacturer Narrative
This report is being submitted as follow up no.1 to provide the completed investigation.The actual device was not returned for evaluation.Therefore, the investigation was based on the user facility information and the device history records.There is no evidence that this event was related to a device defect or malfunction.Based on the results of the investigation, the cause of the event is unable to be determined.All available information has been placed on file in quality assurance at the manufacturing facility for appropriate tracking, trending and follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
6F ANGIO-SEAL EVOLUTION VASCULAR CLOSURE DEVICE, US
Common Device Name
DEVICE, HEMOSTASIS, VASCULAR
Manufacturer (Section D)
TERUMO MEDICAL CORPORATION
2101 cottontail ln.
somerset NJ 08873
MDR Report Key6684130
Report Number2243441-2017-00052
Device Sequence Number16615152
Product Code MGB
UDI-Device Identifier05415067002839
UDI-Public(01)05415067002839(17)171130(10)5769622
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
P930038
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 07/03/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/30/2017
Device Catalogue NumberC610134
Device Lot Number5769622
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Received by Manufacturer 06/08/2017
Supplement Date Received by Manufacturer07/12/2017
Initial Report FDA Received Date07/03/2017
Supplement Report FDA Received Date08/04/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-